| 01/18 | ROCHE ANNUAL GENERAL MEETING 2021 : Exercising of shareholder rights via the ind.. | AQ |
| 01/18 | PRESS RELEASE : Roche Annual General Meeting 2021: Exercising of shareholder rig.. | DJ |
| 01/15 | ROCHE HOLDINGS AG : Deutsche Bank gives a Neutral rating | MD |
| 01/14 | Qiagen warns against using standard tests to track coronavirus variants | RE |
| 01/13 | CHUGAI PHARMACEUTICAL : Conducts Digital Transformation in Manufacturing with IB.. | AQ |
| 01/13 | ROCHE : Exane BNP Paribas Lowers Price Target on Roche, Maintains Outperform Rec.. | MT |
| 01/13 | ROCHE HOLDINGS AG : JP Morgan reiterates its Neutral rating | MD |
| 01/12 | ROCHE : Unit Regeneron to Supply Additional Doses of COVID-19 Antibody Cocktail .. | MT |
| 01/12 | ROCHE : confirms US government agreement to purchase additional doses of Regener.. | AQ |
| 01/12 | PRESS RELEASE : Roche confirms US government -2- | DJ |
| 01/12 | PRESS RELEASE : Roche confirms US government agreement to purchase additional do.. | DJ |
| 01/12 | ROCHE : CHEPLAPHARM acquires the rights to Rivotril | AQ |
| 01/12 | ROCHE HOLDINGS AG : Receives a Buy rating from UBS | MD |
| 01/12 | ROCHE : Tecentriq-Avastin Treatment Improves Survival Rate in Liver Cancer Patie.. | MT |
| 01/12 | ROCHE : to present updated data confirming Tecentriq in combination with Avastin.. | AQ |
| 01/12 | PRESS RELEASE : Roche to present updated data -2- | DJ |
| 01/12 | PRESS RELEASE : Roche to present updated data confirming Tecentriq in combinatio.. | DJ |
| 01/11 | REGENERON PHARMACEUTICALS : says antibodies likely potent vs virus variants, Lil.. | RE |
| 01/11 | GLOBAL MARKETS LIVE: Tech giants and freedom of expression | |
| 01/11 | ROCHE : Trial of COVID-19 blood plasma finds no benefit in severely ill patients | RE |
| 01/11 | Regeneron says COVID-19 antibody therapy will likely help against variants | RE |
| 01/11 | ROCHE : Trial of COVID-19 blood plasma finds no benefit in severely ill patients | RE |
| 01/11 | ROCHE : Xofluza approved by the European Commission for the treatment of influen.. | AQ |
| 01/11 | Soaring virus cases knock European stocks off 10-month high | RE |
| 01/11 | ROCHE : Correction to Roche Influenza Treatment Article | DJ |
| 01/11 | ROCHE : Influenza Treatment Approved by European Commission | DJ |
| 01/11 | ROCHE : Debuts Two Automated Digital Pathology Image Analysis Algorithms for Bre.. | MT |
| 01/11 | ROCHE : Gets EU Approval for Influenza Treatment Xofluza | MT |
| 01/11 | ROCHE : gets EU green light for influenza treatment Xofluza | RE |
| 01/11 | ROCHE : launches two digital pathology image analysis algorithms for precision p.. | AQ |
| 01/11 | PRESS RELEASE : Roche launches two digital pathology image analysis algorithms f.. | DJ |
| 01/11 | ROCHE : Xofluza approved by the European Commission for the treatment of influen.. | AQ |
| 01/11 | PRESS RELEASE : Roche's Xofluza approved by the -2- | DJ |
| 01/11 | PRESS RELEASE : Roche's Xofluza approved by the European Commission for the trea.. | DJ |
| 01/08 | COVID SCIENCE-Pfizer/BioNTech vaccine works against virus variants in lab; ar.. | RE |
| 01/08 | Coronavirus variants may lead to false negative results with molecular tests .. | RE |
| 01/08 | ROCHE HOLDINGS AG : Morgan Stanley is less optimistic | MD |
| 01/08 | ROCHE : Morgan Stanley Maintains Price Target on Roche, Downgrades Recommendatio.. | MT |
| 01/08 | ROCHE HOLDINGS AG : Berenberg gives a Neutral rating | MD |
| 01/07 | ROCHE : Sanofi Arthritis Drugs Lower Fatality Rates in Severe COVID-19 Patients | MT |
| 01/07 | Roche, Sanofi arthritis drugs reduce death rates among sickest COVID-19 patie.. | RE |
| 01/07 | ROCHE HOLDINGS AG : Credit Suisse sticks Neutral | MD |
| 01/05 | ROCHE : Genentech Gets FDA Breakthrough Designation for Tiragolumab Combo | DJ |
| 01/05 | ROCHE : Invitation to Roche's Full Year Results 2020 Presentation | PU |
| 01/05 | ROCHE : Tiragolumab-Tecentriq Treatment for Lung Cancer Gets US FDA Breakthrough.. | MT |
| 01/05 | GENENTECH : 's Novel Anti-TIGIT Tiragolumab Granted FDA Breakthrough Therapy Des.. | BU |
| 01/05 | ROCHE : novel anti-TIGIT tiragolumab granted FDA Breakthrough Therapy Designatio.. | AQ |
| 01/05 | PRESS RELEASE : Roche's novel anti-TIGIT -2- | DJ |
| 01/05 | PRESS RELEASE : Roche's novel anti-TIGIT tiragolumab granted FDA Breakthrough Th.. | DJ |
| 01/04 | ROCHE HOLDINGS AG : Gets a Buy rating from Bernstein | MD |
| 01/04 | ROCHE HOLDINGS AG : JP Morgan gives a Neutral rating | MD |
| 2020 | Chugai Obtains Approval for Expanded Use of FoundationOne CDx Cancer Genomic .. | AQ |
| 2020 | HALOZYME THERAPEUTICS : Announces Roche Receives European Commission Approval fo.. | AQ |
| 2020 | ROCHE : Says New COVID-19 Strains Will Not Impact Tests | MT |
| 2020 | Britain, Swiss firm Roche say COVID-19 tests can detect mutant virus | RE |
| 2020 | CHUGAI PHARMACEUTICAL THE : Launch of Chugai's New TV Commercial Featuring Erika.. | AQ |
| 2020 | GLOBAL MARKETS LIVE : Airbus, Walmart, Roche… | |
| 2020 | ROCHE : Phesgo Breast Cancer Treatment Approved by European Commission | MT |
| 2020 | ROCHE : European Commission approves Roche's Phesgo (fixed-dose combination of P.. | AQ |
| 2020 | PRESS RELEASE : European Commission approves -2- | DJ |
| 2020 | PRESS RELEASE : European Commission approves Roche's Phesgo (fixed-dose combinat.. | DJ |
| 2020 | ROCHE : Bank Vontobel Lifts Price Target on Roche, Maintains Buy Recommendation | MT |
| 2020 | GLOBAL MARKETS LIVE: Tesla, Apple, Lockheed Martin… | |
| 2020 | CHUGAI PHARMACEUTICAL : Osteoporosis Agent Edirol Obtains Regulatory Approval in.. | AQ |
| 2020 | ROCHE HOLDINGS AG : Buy rating from JP Morgan | MD |
| 2020 | ASTRAZENECA : Tagrisso gets broader U.S. FDA nod for lung cancer | RE |
| 2020 | ROCHE : Faricimab Meets Primary Endpoint in Two Phase 3 Studies | DJ |
| 2020 | ROCHE : Eye Drug Faricimab Shows Durability in Late-Stage Clinical Studies | MT |
| 2020 | ROCHE : EU Signs $122 Million Deal for COVID-19 Rapid Antigen Tests From Abbott,.. | MT |
| 2020 | ROCHE : faricimab meets primary endpoint and shows strong durability across two .. | AQ |
| 2020 | GENENTECH : 's Faricimab Meets Primary Endpoint and Shows Strong Durability Acro.. | BU |
| 2020 | PRESS RELEASE : Roche's faricimab meets primary -2- | DJ |
| 2020 | PRESS RELEASE : Roche's faricimab meets primary endpoint and shows strong durabi.. | DJ |
| 2020 | REGENERON PHARMACEUTICALS : New England Journal of Medicine Publishes Positive I.. | AQ |
| 2020 | ROCHE : Diagnostics to create Software Development Hub in Laval, Quebec | AQ |
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
